Atopic dermatitis has a significant impact on the quality of life of patients, particularly with regards to burden of itch and sleep loss. Using diagnostic criteria to identify patients with atopic dermatitis is critical, as is utilizing disease severity assessment tools such as the Patient-Oriented Eczema Measure (POEM). These tools can help improve diagnostic accuracy, evaluate disease severity, and monitor response to treatment. Documentation of these assessments is also becoming increasingly necessary in order to help demonstrate the value of high-cost interventions. We invite you to participate in a quality improvement initiative with 10 of your patients who have atopic dermatitis, where you will document aspects of disease related to AD using diagnostic assessments, POEM, and the Hospital Anxiety and Depression Scale (HADS). Once you complete the follow-up survey and enter the chart data, you will be paid an honorarium of $400.
Zelma C. Chiesa Fuxench, MD, MSCE
Department of Dermatology
University of Pennsylvania Perelman School of Medicine